Fred Kirsten

816 total citations
8 papers, 149 citations indexed

About

Fred Kirsten is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Fred Kirsten has authored 8 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Fred Kirsten's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Cancer Diagnosis and Treatment (2 papers). Fred Kirsten is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Cancer Diagnosis and Treatment (2 papers). Fred Kirsten collaborates with scholars based in Australia, United Kingdom and Belgium. Fred Kirsten's co-authors include David W. Hedley, Jennifer Leary, Martin H.N. Tattersall, Michael Friedländer, Heng Cao, Alan B. P. Ng, Mary Ryan, Perry Elliott, Paul de Souza and John Murray and has published in prestigious journals such as Journal of Clinical Oncology, BJOG An International Journal of Obstetrics & Gynaecology and QJM.

In The Last Decade

Fred Kirsten

6 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fred Kirsten Australia	5	77	50	46	33	32	8	149
Jorge S. Reis-Filho United States	5	40 0.5×	28 0.6×	19 0.4×	16 0.5×	28 0.9×	6	106
Virginia Mancini Italy	9	76 1.0×	62 1.2×	13 0.3×	20 0.6×	29 0.9×	30	203
J F Rodier France	7	52 0.7×	66 1.3×	53 1.2×	5 0.2×	46 1.4×	33	178
Yoshinao Takano Japan	9	66 0.9×	18 0.4×	6 0.1×	23 0.7×	50 1.6×	31	179
L Galletto Italy	5	58 0.8×	16 0.3×	108 2.3×	38 1.2×	32 1.0×	8	166
Petra Jankowska United Kingdom	4	34 0.4×	12 0.2×	43 0.9×	34 1.0×	31 1.0×	6	141
Maria Teresa Ricci Italy	9	92 1.2×	108 2.2×	7 0.2×	7 0.2×	29 0.9×	30	225
Annick Chevalier-Place France	6	56 0.7×	19 0.4×	42 0.9×	26 0.8×	27 0.8×	7	148
Giorgia Trevisan United Kingdom	7	54 0.7×	15 0.3×	35 0.8×	15 0.5×	44 1.4×	11	143
Herman Charache United States	6	30 0.4×	27 0.5×	6 0.1×	19 0.6×	24 0.8×	16	119

Countries citing papers authored by Fred Kirsten

Since Specialization

Citations

This map shows the geographic impact of Fred Kirsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Kirsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Kirsten more than expected).

Fields of papers citing papers by Fred Kirsten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Kirsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Kirsten. The network helps show where Fred Kirsten may publish in the future.

Co-authorship network of co-authors of Fred Kirsten

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Kirsten. A scholar is included among the top collaborators of Fred Kirsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Kirsten. Fred Kirsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Burns, W. Ivon, Christos S. Karapetis, Ray M. Lowenthal, et al.. (2009). Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non‐small‐cell lung cancer: Is thrombocytopenia predictable?. Asia-Pacific Journal of Clinical Oncology. 5(1). 24–31.

2.

Links, Matthew, Shaun R. D. Watson, Wynne Aherne, et al.. (1999). Vinblastine Pharmacokinetics in Patients with Non-Small Cell Lung Cancer Given Cisplatin. Cancer Investigation. 17(7). 479–485. 3 indexed citations

3.

Souza, Paul de, Michael Friedländer, C E Wilde, Fred Kirsten, & Mary Ryan. (1994). Hypersensitivity Reactions to Etoposide. American Journal of Clinical Oncology. 17(5). 387–389. 22 indexed citations

4.

Kirsten, Fred, Kenneth Atkinson, Perry Elliott, et al.. (1987). Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. BJOG An International Journal of Obstetrics & Gynaecology. 94(6). 583–588. 49 indexed citations

5.

Kirsten, Fred, Heng Cao, Jennifer Leary, et al.. (1987). Metastatic Adeno or Undifferentiated Carcinoma from an Unknown Primary Site Natural History and Guidelines for Identification of Treatable Subsets. QJM. 62(238). 143–61. 33 indexed citations

6.

Harnett, Paul R., Fred Kirsten, & M.H.N. Tattersall. (1986). Drug resistance in clinical practice: patterns of treatment failure in advanced breast and ovarian cancer.. Journal of Clinical Oncology. 4(6). 952–957. 10 indexed citations

7.

Hedley, David W., Jennifer Leary, & Fred Kirsten. (1985). Metastatic adenocarcinoma of unknown primary site: Abnormalities of cellular DNA content and survival. European Journal of Cancer and Clinical Oncology. 21(2). 185–189. 32 indexed citations

8.

Goodman, C. D., et al.. (1970). On the Merits of Interface Standardization-A Round Table Discussion. IEEE Transactions on Nuclear Science. 17(1). 376–382.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact